Richard Kay

4.3k total citations
79 papers, 3.2k citations indexed

About

Richard Kay is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Richard Kay has authored 79 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 16 papers in Epidemiology and 16 papers in Physiology. Recurrent topics in Richard Kay's work include Acute Ischemic Stroke Management (11 papers), Cerebrovascular and Carotid Artery Diseases (10 papers) and Asthma and respiratory diseases (10 papers). Richard Kay is often cited by papers focused on Acute Ischemic Stroke Management (11 papers), Cerebrovascular and Carotid Artery Diseases (10 papers) and Asthma and respiratory diseases (10 papers). Richard Kay collaborates with scholars based in United Kingdom, Hong Kong and United States. Richard Kay's co-authors include Ka Sing Wong, Yu Leung Chan, Esther Crawley, Ian V. Hutchinson, Pritash Patel, James Sillibourne, Patricia Woo, Wynnie W.M. Lam, Ying‐Chih Huang and Y. L. Chan and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Neurology.

In The Last Decade

Richard Kay

77 papers receiving 3.1k citations

Peers

Countries citing papers authored by Richard Kay

Since Specialization

Citations

This map shows the geographic impact of Richard Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Kay more than expected).

Fields of papers citing papers by Richard Kay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Kay. The network helps show where Richard Kay may publish in the future.

Co-authorship network of co-authors of Richard Kay

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Kay. A scholar is included among the top collaborators of Richard Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Kay. Richard Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study 2021 ·BioDrugs ·Steven R. Feldman, (unknown), Grażyna Pulka, Külli Kingo, (unknown), Fausto Berti, (unknown), (unknown), Eric Guenzi, (unknown), (unknown), Richard Kay, (unknown)	22
2	Fevipiprant, an oral prostaglandin DP₂receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids 2017 ·European Respiratory Journal ·Eric D. Bateman, (unknown), Florian Brockhaus, Björn Holzhauer, Abhijit Pethe, Richard Kay, Robert G. Townley	85
3	Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling 2017 ·European Respiratory Journal ·Rachid Berair, Ruth Hartley, Vijay Mistry, Ajay Sheshadri, Sumit Gupta, Amisha Singapuri, Sherif Gonem, Richard P. Marshall, Ana R. Sousa, Aarti Shikotra, Richard Kay, Andrew J. Wardlaw, Peter Bradding, Salman Siddiqui, Mario Castro, Christopher E. Brightling	31
4	Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY) 2016 ·World Journal of Urology ·Paul Abrams, Con Kelleher, David Staskin, Richard Kay, A Martan, (unknown), Donald Newgreen, Arwin Ridder, Asha Paireddy, (unknown)	37
5	Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center study 2016 ·Journal of Allergy and Clinical Immunology ·Ruth Hartley, Bethan L. Barker, Chris Newby, Mini Pakkal, S. Baldi, Radhika Kajekar, Richard Kay, (unknown), Richard P. Marshall, Ana R. Sousa, (unknown), Salman Siddiqui, Sumit Gupta, Christopher E. Brightling	78
6	Effect Of Qaw039, An Oral Prostaglandin D2 Receptor (dp2/crth2) Antagonist, Upon Sputum And Bronchial Eosinophilic Inflammation And Clinical Outcomes In Treatment-Resistant Asthma: A Phase 2a Randomized Placebo-Controlled Trial 2015 ·American Journal of Respiratory and Critical Care Medicine ·Rachid Berair, Sherif Gonem, Amisha Singapuri, Ruth Hartley, (unknown), Gerald Bacher, Björn Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord, (unknown), Andrew J. Wardlaw, (unknown), Richard Kay, Christopher E. Brightling	6
7	Comparison of CT-based Lobar Ventilation with³He MR Imaging Ventilation Measurements 2015 ·Radiology ·Bilal Tahir, Cedric Van Holsbeke, Rob H. Ireland, Andrew J. Swift, Felix Horn, Helen Marshall, (unknown), Juan Parra‐Robles, Ruth Hartley, Richard Kay, Christopher E. Brightling, Jan De Backer, Wim Vos, Jim M. Wild	32
8	Characterization of acinar airspace involvement in asthmatic patients by using inert gas washout and hyperpolarized 3helium magnetic resonance 2015 ·Journal of Allergy and Clinical Immunology ·Sherif Gonem, (unknown), (unknown), Ruth Hartley, (unknown), Richard Kay, (unknown), Per Gustafsson, Christopher E. Brightling, J. R. Owers-Bradley, Salman Siddiqui	24
9	Comparison of CT-based lobar ventilation models with helium-3 MRI ventilation measurements in asthmatics 2014 ·Ghent University Academic Bibliography (Ghent University) ·Bilal Tahir, Cedric Van Holsbeke, Rob H. Ireland, (unknown), Felix Horn, Helen Marshall, Juan Parra‐Robles, Ruth Hartley, (unknown), Richard Kay, Salman Siddiqui, Christopher E. Brightling, Jan De Backer, Wim Vos, Jim M. Wild	1
10	Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony) 2014 ·European Urology ·Paul Abrams, Con Kelleher, David Staskin, Tomasz Rechberger, Richard Kay, Reynaldo Martina, Donald Newgreen, Asha Paireddy, Rob van Maanen, Arwin Ridder	163
11	Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: A randomised controlled 6-week trial 2011 ·Pulmonary Pharmacology & Therapeutics ·H Magnussen, Henrik Watz, Anne Kirsten, Millie Wang, Heather Wray, (unknown), John Mo, Richard Kay	26
12	LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951) 2009 ·European Journal of Cancer ·Sanjiv S. Agarwala, Ulrich Keilholz, (unknown), Agop Y. Bedikian, Jane Wu, Richard Kay, Cy A. Stein, Loretta M. Itri, Stefan Suciu, Alexander M.M. Eggermont	106
13	Electrophysiological, clinical and epidemiological study of Guillain–Barré Syndrome in Hong Kong Chinese 2004 ·Journal of Clinical Neuroscience ·Andrew Hui, Kai Ming Chow, (unknown), Michael Fu, Richard Kay, Ka Sing Wong	18
14	Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: A diffusion‐weighted imaging and microemboli monitoring study 2002 ·Annals of Neurology ·Ka Sing Wong, Shan Gao, Yu Leung Chan, Tjark Hansberg, Wynnie W.M. Lam, Dirk W. Droste, Richard Kay, E. Bernd Ringelstein	194
15	ISCHAEMIC MYELOPATHY PRESENTING AS GUILLAIN‐BARRÉ SYNDROME 2000 ·International Journal of Clinical Practice ·(unknown), Ka Sing Wong, Michael Fu, Richard Kay	3
16	Polymorphic haplotypes of the interleukin-10 5? flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis 1999 ·Arthritis & Rheumatism ·Esther Crawley, Richard Kay, James Sillibourne, Pritash Patel, Ian V. Hutchinson, Patricia Woo	437
17	MRI demonstration of subarachnoid neurocysticercosis simulating metastatic disease 1998 ·Neuroradiology ·(unknown), Derek Roebuck, Vincent Mok, Ho‐Keung Ng, Joseph M. Lam, Jennifer Gek Choo Teo, Richard Kay, Wai Sang Poon, C. Metreweli	6
18	SUBDURAL EFFUSION IN CHRONIC CRYPTOCOCCAL MENINGITIS IN A CIRRHOTIC PATIENT 1997 ·International Journal of Clinical Practice ·(unknown), (unknown), Richard Kay, Ho‐Keung Ng	1
19	Putaminal and thalamic hemorrhage in ethnic Chinese living in Hong Kong 1996 ·Surgical Neurology ·John N. K. Hsiang, (unknown), Ka Sing Wong, Richard Kay, W. S. Poon	5
20	Genetic control of the human Vβ13.2 T cell repertoire: importance of allelic variation outside the coding regions of the TCRBV13S2 gene 1994 ·European Journal of Immunology ·Richard Kay, Neil Snowden, Ali H. Hajeer, A W Boylston, William Ollier	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact